Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL, Pandemic H1N1 Vaccine Adult Study Group
Vaccine. 2012 30 (28): 4240-8

PMID: 22537984 · PMCID: PMC3490194 · DOI:10.1016/j.vaccine.2012.04.044

MeSH Terms (20)

Adjuvants, Immunologic Adolescent Adult Aged Aged, 80 and over Antibodies, Viral Double-Blind Method Drug-Related Side Effects and Adverse Reactions Female Hemagglutination Inhibition Tests Humans Influenza, Human Influenza A Virus, H1N1 Subtype Influenza Vaccines Injections, Intramuscular Male Middle Aged United States Vaccines, Inactivated Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: